These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 36005937)

  • 1. Effects of Adjuvant Medications on A1C, Body Mass Index, and Insulin Requirements among Patients with Type 1 Diabetes.
    Silva Almodóvar A; Clevenger J; Nahata MC
    Pharmacy (Basel); 2022 Aug; 10(4):. PubMed ID: 36005937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effectiveness of continuous subcutaneous insulin pumps with continuous glucose monitoring in outpatient adolescents with type 1 diabetes: A systematic review.
    Matsuda E; Brennan P
    JBI Libr Syst Rev; 2012; 10(42 Suppl):1-10. PubMed ID: 27820140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamics of Hemoglobin A1c, Body Mass Index, and Rates of Severe Hypoglycemia in 4434 Adults with Type 1 or Type 2 Diabetes After Initiation of Continuous Glucose Monitoring.
    Lanzinger S; Best F; Bergmann T; Laimer M; Lipovsky B; Danne T; Zimny S; Bramlage P; Meyhöfer S; Holl RW
    Diabetes Technol Ther; 2022 Oct; 24(10):763-769. PubMed ID: 35653726
    [No Abstract]   [Full Text] [Related]  

  • 4. Positive Impact of Continuous-Flow Left Ventricular Assist Device Implantation on Glycemic Control in Patients with Type 2 Diabetes Mellitus and Advanced Chronic Systolic Heart Failure.
    Yen DC; Watson MH; Burgess LD; Kuchibhatla M; Patel CB; Campbell KB; Vora AK
    Pharmacotherapy; 2016 Dec; 36(12):1210-1216. PubMed ID: 27779786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-World Health Outcomes of Insulin Glargine 300 U/mL vs Insulin Glargine 100 U/mL in Adults With Type 1 and Type 2 Diabetes in the Canadian LMC Diabetes Patient Registry: The REALITY Study.
    Abitbol A; Brown RE; Jiandani D; Sauriol L; Aronson R
    Can J Diabetes; 2019 Oct; 43(7):504-509.e1. PubMed ID: 31256905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycemic Outcomes with Early Initiation of Continuous Glucose Monitoring System in Recently Diagnosed Patients with Type 1 Diabetes.
    Mulinacci G; Alonso GT; Snell-Bergeon JK; Shah VN
    Diabetes Technol Ther; 2019 Jan; 21(1):6-10. PubMed ID: 30575413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Flash Continuous Glucose Monitoring Is Associated With A1C Reduction in People With Type 2 Diabetes Treated With Basal Insulin or Noninsulin Therapy.
    Wright EE; Kerr MSD; Reyes IJ; Nabutovsky Y; Miller E
    Diabetes Spectr; 2021 May; 34(2):184-189. PubMed ID: 34149259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Achieving Time in Range Clinical Targets With Treatment Modality Among Youths With Type 1 Diabetes.
    Dovc K; Lanzinger S; Cardona-Hernandez R; Tauschmann M; Marigliano M; Cherubini V; Preikša R; Schierloh U; Clapin H; AlJaser F; Pelicand J; Shukla R; Biester T
    JAMA Netw Open; 2023 Feb; 6(2):e230077. PubMed ID: 36808243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: the RealTrend study.
    Raccah D; Sulmont V; Reznik Y; Guerci B; Renard E; Hanaire H; Jeandidier N; Nicolino M
    Diabetes Care; 2009 Dec; 32(12):2245-50. PubMed ID: 19767384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proportion of Basal to Total Insulin Dose Is Associated with Metabolic Control, Body Mass Index, and Treatment Modality in Children with Type 1 Diabetes-A Cross-Sectional Study with Data from the International SWEET Registry.
    Rasmussen VF; Vestergaard ET; Schwandt A; Beltrand J; Rami-Merhar B; O'Riordan SMP; Jarosz-Chobot P; Castro-Correia C; Gevers EF; Birkebæk NH
    J Pediatr; 2019 Dec; 215():216-222.e1. PubMed ID: 31345576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin pump use in young children in the T1D Exchange clinic registry is associated with lower hemoglobin A1c levels than injection therapy.
    Blackman SM; Raghinaru D; Adi S; Simmons JH; Ebner-Lyon L; Chase HP; Tamborlane WV; Schatz DA; Block JM; Litton JC; Raman V; Foster NC; Kollman CR; DuBose SN; Miller KM; Beck RW; DiMeglio LA
    Pediatr Diabetes; 2014 Dec; 15(8):564-72. PubMed ID: 24494980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabetes.
    Karter AJ; Parker MM; Moffet HH; Gilliam LK; Dlott R
    JAMA; 2021 Jun; 325(22):2273-2284. PubMed ID: 34077502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Technology in Older Adults with Type 1 Diabetes: Clinical Characteristics and Glycemic Metrics.
    Munshi M; Slyne C; Davis D; Michals A; Sifre K; Dewar R; Atakov-Castillo A; Toschi E
    Diabetes Technol Ther; 2022 Jan; 24(1):1-9. PubMed ID: 34524033
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of Social Factors in Glycemic Control Among African American Children and Adolescents with Type 1 Diabetes.
    Agarwal S; Khokhar A; Castells S; Marwa A; Hagerty D; Dunkley L; Cooper J; Chin V; Umpaichitra V; Perez-Colon S
    J Natl Med Assoc; 2019 Feb; 111(1):37-45. PubMed ID: 30129485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment Dosing Patterns and Clinical Outcomes for Patients with Type 2 Diabetes Starting or Switching to Treatment with Insulin Glargine (300 Units per Milliliter) in a Real-World Setting: A Retrospective Observational Study.
    Gupta S; Wang H; Skolnik N; Tong L; Liebert RM; Lee LK; Stella P; Cali A; Preblick R
    Adv Ther; 2018 Jan; 35(1):43-55. PubMed ID: 29313285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Multicenter Real-Life Study on the Effect of Flash Glucose Monitoring on Glycemic Control in Patients with Type 1 and Type 2 Diabetes.
    Anjana RM; Kesavadev J; Neeta D; Tiwaskar M; Pradeepa R; Jebarani S; Thangamani S; Sastry NG; Brijendra Kumar S; Ramu M; Gupta PPK; Vignesh J; Chandru S; Kayalvizhi S; Jagdish PS; Uthra SCB; Lovelena M; Jyoti S; Suguna Priya S; Kannan A; Mohan V; Unnikrishnan R
    Diabetes Technol Ther; 2017 Sep; 19(9):533-540. PubMed ID: 28930495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of real-time continuous glucose monitoring on glycemic control in patients with type 2 diabetes mellitus.
    Ehrhardt NM; Chellappa M; Walker MS; Fonda SJ; Vigersky RA
    J Diabetes Sci Technol; 2011 May; 5(3):668-75. PubMed ID: 21722581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The Impact of Prolonged Use of Continuous Subcutaneous Insulin Infusion in the Control of Type-1 Diabetes].
    Azevedo S; Saraiva J; Caramelo F; Fadiga L; Barros L; Baptista C; Melo M; Gomes L; Carrilho F
    Acta Med Port; 2019 Feb; 32(1):17-24. PubMed ID: 30753799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethnic disparity in hemoglobin A1c levels among normoglycemic offspring of parents with type 2 diabetes mellitus.
    Chapp-Jumbo E; Edeoga C; Wan J; Dagogo-Jack S;
    Endocr Pract; 2012; 18(3):356-62. PubMed ID: 22138077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between BMI and glycated albumin to glycated hemoglobin (GA/A1c) ratio according to glucose tolerance status.
    Huh JH; Kim KJ; Lee BW; Kim DW; Kang ES; Cha BS; Lee HC
    PLoS One; 2014; 9(2):e89478. PubMed ID: 24586809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.